| No. |
Gene symbol |
Full name |
Function |
| 1 |
VCAN |
Versican |
Pathways: chondroitin sulfate/dermatan sulfate metabolism and diseases of glycosylation. GO: calcium ion binding and extracellular matrix structural constituent |
| 2 |
CAV1 |
Caveolin 1 |
Pathways: Focal Adhesion and TNF signaling (REACTOME). GO: identical protein binding and signaling receptor binding. |
| 3 |
EPCAM |
Epithelial Cell Adhesion Molecule |
Pathways: Cell surface interactions at the vascular wall and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers |
| 4 |
EGF |
Epidermal Growth Factor |
Pathways: Gastric cancer and Vesicle-mediated transport. GO: calcium ion binding and epidermal growth factor receptor binding. |
| 5. |
GPC3 |
Glypican 3 |
Pathways: Chondroitin sulfate/dermatan sulfate metabolism and Metabolism of fat-soluble vitamins. GO: heparan sulfate proteoglycan binding and peptidyl-dipeptidase inhibitor activity. |
| 6 |
CCL5 |
C-C Motif Chemokine Ligand 5 |
Pathways: PEDF Induced Signaling and Innate Immune System. GO: protein homodimerization activity and chemokine activity. |
| 7 |
CSF1R |
Colony Stimulating Factor 1 Receptor |
Pathways: GPCR Pathway and Nanog in Mammalian ESC Pluripotency. GO: protein homodimerization activity and protein kinase activity. |
| 8 |
TIMP1 |
TIMP Metallopeptidase Inhibitor 1 |
Pathways: GPCR Pathway and Matrix Metalloproteinases. GO: cytokine activity and protease binding. |
| 9 |
COL1A1 |
Collagen Type I Alpha 1 Chain |
Pathways: IL4-mediated signaling events and Integrin Pathway. GO: identical protein binding and platelet-derived growth factor binding. |
| 10 |
DCN |
Decorin |
Pathways: Chondroitin sulfate/dermatan sulfate metabolism and Diseases of glycosylation. GO: collagen binding. |
| 11 |
VEGFA |
Vascular Endothelial Growth Factor A |
Pathways: VEGF Signaling Pathway and Bladder cancer. GO: protein homodimerization activity and protein heterodimerization activity. |
| 12 |
KNG1 |
Kininogen 1 |
Pathways: Collagen chain trimerization and amb2 Integrin signaling. GO: signaling receptor binding and cysteine-type endopeptidase inhibitor activity. |
| 13 |
ITGB1 |
Integrin Subunit Beta 2 |
Pathways: Activated TLR4 signalling and Focal Adhesion. GO: protein heterodimerization activity. |
| 14 |
IGFBP3 |
Insulin Like Growth Factor Binding Protein 3 |
Pathways: TP53 Regulates Transcription of Cell Death Genes and Celecoxib Pathway, Pharmacodynamics. GO: fibronectin binding and insulin-like growth factor I binding. |
| 15 |
ALB |
Albumin |
Pathways: Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) and Synthesis of bile acids and bile salts. GO: enzyme binding and chaperone binding. |
| 16 |
CD163 |
CD163 Molecule |
Pathways: Binding and Uptake of Ligands by Scavenger Receptors and Dendritic Cells Developmental Lineage Pathway. GO: scavenger receptor activity. |
| 17 |
CASR Calcium Sensing Receptor |
Pathways: Parathyroid hormone synthesis, secretion and action and E-cadherin signaling in keratinocytes. GO: G protein-coupled receptor activity and protein kinase binding. |
| 18 |
ITGA5 |
Integrin Subunit Alpha 5 |
Pathways: Cell surface interactions at the vascular wall and Focal Adhesion. GO: integrin binding and epidermal growth factor receptor binding. |
| 19 |
AQP2 |
Aquaporin 2 |
Pathways: Aquaporin-mediated transport and Glucose / Energy Metabolism. GO: actin binding and PDZ domain binding. |
| 20 |
SLC12A1 |
Solute Carrier Family 12 Member 1 |
Pathways: Neuroscience and Diuretics Pathway, Pharmacodynamics. GO: transporter activity and sodium:potassium:chloride symporter activity. |
